Table of Contents Table of Contents
EURURO Vol. 71 No. 4 Next Page
Information
Show Menu
EURURO Vol. 71 No. 4 Next Page

 




EAU Recommendations
XXV

The Role of Urodynamics in the Evaluation of Urinary Incontinence: The European Association of Urology Recommendations in 2016
XXV

Medical Expulsive Therapy for Ureterolithiasis: The EAU Recommendations in 2016
XXVIII

Platinum Opinion
XXXII

Open Access. Open Science. Open Urology
XXXII

Platinum Priorities
XXXV

Generalizability of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) Results to Contemporary North American Men with Prostate Cancer
XXXV

Brief Correspondence
XXXIX

Generalizability of Clinical Trials: Why It Matters for Patients and Public Policy
XXXIX

Prostate Cancer
XLI

Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
XLI

Magnetic Resonance Imaging–targeted Prostate Biopsies: Is the Right Technique the Right Question?
LVI

Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial
LVIII

The Effect of Enzalutamide and Bicalutamide on Patient-reported Quality of Life Outcomes: Results from the TERRAIN Study
LXVII

Urothelial Cancer
LXIX

Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy
LXIX

Facing the Fate of the Remnant Urothelium After Radical Cystectomy: There Is Room for Improvement
LXXXII

Kidney Cancer
LXXXIV

Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis
LXXXIV

The Role of Lymphadenectomy for Renal Cell Carcinoma: Are we any Closer to an Answer?
XCII

Benign Prostatic Hyperplasia
XCIV

Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
XCIV

Medical Treatment of Male Lower Urinary Tract Symptoms: Does One Fit All?
CVI

Reconstructive Urology
CVIII

Ex Vivo Model of Human Penile Transplantation and Rejection: Implications for Erectile Tissue Physiology
CVIII

Getting Ready for Penile Transplantation
CXVIII

Reviews
CXX

Prostate Cancer
CXX

Sentinel Node Procedure in Prostate Cancer: A Systematic Review to Assess Diagnostic Accuracy
CXX

Kidney Cancer
CXXX

Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies
CXXX

Guidelines
CXLII

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
CXLII

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
CLIV

Surgery in Motion
CLXVII

Robotic Laparoendoscopic Single-site Retroperitioneal Renal Surgery: Initial Investigation of a Purpose-built Single-port Surgical System
CLXVII

Original Articles
CLXXII

Prostate Cancer
CLXXII

Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations—A Report of a European School of Oncology Task Force
CLXXII

Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302
CLXXX

Kidney Cancer
CLXXXIX

Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients
CLXXXIX

Incontinence
CXCVIII

Tension-free Vaginal Tape–Obturator for Treatment of Pure Urodynamic Stress Urinary Incontinence: Efficacy and Adverse Effects at 10-year Follow-up
CXCVIII

From Lab to Clinic
CCIV

The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients
CCIV

Words of Wisdom
CCXII

Re: Management of Nonmuscle Invasive Bladder Cancer: A Comprehensive Analysis of Guidelines from the Unites States, Europe, and Asia
CCXII

Re: Low Adherence to Guidelines in Nonmuscle-invasive Disease
CCXIII

Re: Analysis of Papillary Urothelial Carcinomas of the Bladder with Grade Heterogeneity: Supportive Evidence for an Early Role of CDKN2A Deletions in the FGFR3 Pathway
CCXIV

Re: The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial
CCXIV

Re: Detection of Micrometastases by Flow Cytometry in Sentinel Lymph Nodes from Patients with Renal Tumours
CCXV

Re: Inherited DNA-repair Gene Mutations in Men with Metastatic Prostate Cancer
CCXVI

Letters to the Editor published online
CCXVII

Re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol 2017;71:1–3
CCXVII

Reply to Marcus V. Cronauer, Axel S. Merseburger, and M. Raschid Hoda’s Letter to the Editor re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response toNext Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol 2017;71:1–3
CCXIX

Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol 2016;70:1052–68 Preoperative Bladder Cancer History and Chronic Kidney Disease Are Associated with Occult Renal Pelvis Cancer in Preoperative Solitary Ureteral Cancer
CCXXI

Reply to Hao Lun Luo, Yen Ta Chen, Yuan Tso Cheng, and Po Hui Chiang’s Letter to the Editor re: Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol 2016;70:1052–68 The Key Role of Flexible Ureterorenoscopy in Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma
CCXXIII

Re: Pär Stattin, Fredrik Sandin, Frederik Birkebæk Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023 Radical Treatment in Very High-risk Prostate Cancer: Venturing Down a Path Less Travelled
CCXXV

Reply to Glen Denmer Santok and Koon Ho Rha’s Letter to the Editor re: Pär Stattin, Fredrik Sandin, Frederik Birkebæk Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press.
CCXXVII

Re: Mauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol 2016;70:788–96
CCXXIX

Reply to Jae Heon Kim’s Letter to the Editor re: Mauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol 2016;70:788–96
CCXXXI

Re: Daniel E. Spratt, Hebert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71:37–43 A Step Forward in the Era of Functional Imaging?
CCXXXIII

Reply to Filippo Alongi, Rosario Mazzola, Dario Aiello and Matteo Salgarello’s Letter to the Editor re: Re: Daniel E. Spratt, Hebert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71:37–43. A Step Forward in the Era of Functional Imaging?Functional Imaging and Micrometastatic Disease: Implications for Radiotherapy Field Design
CCXXXV

Congress Calendar
CCXXXVII